S&P Global Expands Databricks Partnership, Adds Capital IQ Pro Datasets for Enhanced Analytics
The enhancement enables users to directly access and query a range of additional S&P Global datasets, such as financials, estimates, filings, transcripts, transactions, and sustainability data, without requiring data ingestion.
A group of analysts studying data on a large monitor.
The datasets are valuable for investment management, risk assessment, and competitive intelligence. Delta Sharing is Databricks' open-source protocol that facilitates the secure sharing of live data across various platforms, clouds, and regions. The technology minimizes data duplication and latency issues, and ensures that investment, risk, and strategy teams can always work with the most current data within their existing Databricks environment.
S&P Global's previous collaborations with Databricks included the integration of energy and commodities datasets from its Commodity Insights division and the development of the S&P Global Capital IQ Workbench, which is a collaborative analytics notebook environment. S&P Global plans to continue adding more datasets to Databricks Delta Sharing, which will be accessible through both the S&P Global Marketplace and Databricks Marketplace.
Warren Breakstone, Head of Data & Research at S&P Global Market Intelligence, emphasized the importance of meeting clients where they are in today's dynamic market. He highlighted that the expanded relationship with Databricks will provide more seamless access and efficient querying. S&P Global Inc. (NYSE: SPGI) provides credit ratings, benchmarks, analytics, and workflow solutions across the global capital, commodity, and automotive markets. Whereas Databricks is a data and AI company
While we acknowledge the potential of SPGI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SPGI and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: and .
Disclosure: None. This article is originally published at Insider Monkey.
擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
27 minutes ago
- Business Wire
Fresh Del Monte Produce Inc. Clarifies It Is Not Affiliated with Del Monte Foods Inc.
CORAL GABLES, Fla.--(BUSINESS WIRE)-- Fresh Del Monte Produce Inc. (NYSE: FDP) is a fully independent, publicly traded company with no financial or operational affiliation with Del Monte Foods Inc., a separate entity currently involved in litigation and bankruptcy proceedings. The two companies are entirely separate entities, with no shared ownership, governance, or operations. Del Monte Foods Inc. is a privately held U.S. company owned by a parent organization based in Singapore. Fresh Del Monte Produce Inc.'s financial or operational performance is not impacted by that separate, unaffiliated company's announced legal or financial proceedings. While both businesses share rights to the Del Monte® name through historical licensing arrangements, they operate under distinct ownership and serve different geographic markets. Fresh Del Monte continues to operate with full stability and focus. The company remains financially strong, strategically aligned, and committed to delivering long-term value. It will report second quarter 2025 results during its scheduled earnings call on Wednesday, July 30, 2025. Fresh Del Monte is a global leader in fresh and fresh-cut produce: Headquartered in Coral Gables, FL, with operations in over 90 countries. The global leader in pineapple innovation. Owner of the Del Monte® brand for prepared food products in Europe, Africa, and the Middle East. Del Monte Foods Inc. — a different company with no affiliation to Fresh Del Monte — holds the rights to the Del Monte® brand for prepared food products in the U.S. It does not have rights to fresh or fresh-cut fruit. Customers, suppliers, and partners can remain confident in the continuity of Fresh Del Monte's operations and its commitment to delivering high-quality, Del Monte®-branded products, services, and trusted support. For more information about the company's global operations and financial performance, please visit the Investor Relations page. Fresh Del Monte Produce Inc. is one of the world's leading vertically integrated producers, marketers, and distributors of high-quality fresh and fresh-cut fruit and vegetables, as well as a leading producer and distributor of prepared food in Europe, Africa, and the Middle East. Fresh Del Monte Produce Inc. markets its products worldwide under the DEL MONTE ® brand (under license from Del Monte Foods, Inc.), a symbol of product innovation, quality, freshness, and reliability for over 135 years. The company also markets its products under the MANN ® brand and other related trademarks. Fresh Del Monte Produce Inc. is not affiliated with certain other Del Monte companies around the world, including Del Monte Foods, Inc., the U.S. subsidiary of Del Monte Pacific Limited, Del Monte Canada, or Del Monte Asia Pte. Ltd. Fresh Del Monte Produce Inc. is the first global marketer of fruits and vegetables to commit to the 'Science Based Targets' initiative. In 2022, 2023, and 2024, Fresh Del Monte Produce was ranked as one of 'America's Most Trusted Companies' by Newsweek based on an independent survey rating companies on three different touchpoints, including customer trust, investor trust, and employee trust. The company was also named a Humankind 100 Company for two consecutive years by Humankind Investments, which recognizes companies that substantially impact areas such as access to food and clean water, healthcare, and digital services. Fresh Del Monte has also been awarded the SEAL Business Sustainability Awards four times in the last five years (2021, 2023, 2024, and 2025). Fresh Del Monte Produce Inc. is traded on the NYSE under the symbol FDP.
Yahoo
27 minutes ago
- Yahoo
Philip Morris International Insiders Sell US$49m Of Stock, Possibly Signalling Caution
The fact that multiple Philip Morris International Inc. (NYSE:PM) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period. Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. In the last twelve months, the biggest single sale by an insider was when the Non-Executive Chairman, Andre Calantzopoulos, sold US$13m worth of shares at a price of US$130 per share. That means that even when the share price was below the current price of US$176, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. It is worth noting that this sale was only 9.6% of Andre Calantzopoulos's holding. Philip Morris International insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Philip Morris International If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Philip Morris International insiders own about US$410m worth of shares (which is 0.1% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders. It doesn't really mean much that no insider has traded Philip Morris International shares in the last quarter. It's heartening that insiders own plenty of stock, but we'd like to see more insider buying, since the last year of Philip Morris International insider transactions don't fill us with confidence. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of Philip Morris International. Of course Philip Morris International may not be the best stock to buy. So you may wish to see this free collection of high quality companies. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and infants who were born during or entering their first RSV season. To provide a brief context, ENFLONSIA happens to be a preventive, long-acting monoclonal antibody (mAb) which has been designed to offer direct, rapid, and durable protection through 5 months, a typical RSV season, with the same 105 mg dose irrespective of weight. Merck & Co., Inc. (NYSE:MRK) further mentioned that the typical RSV season generally spans autumn to spring of the next year. A close-up of a person's hand holding a bottle of pharmaceuticals. However, ENFLONSIA should not be administered to infants who have a history of serious hypersensitivity reactions, including anaphylaxis, to any of the components of ENFLONSIA. Merck & Co., Inc. (NYSE:MRK) added that the approval is basis the results from the pivotal Phase 2b/3 CLEVER trial (MK-1654-004) evaluating a single dose of ENFLONSIA administered to preterm and full-term infants. Furthermore, the focus is to ensure the availability of ENFLONSIA in the US before the upcoming RSV season begins. This is to help in reducing the significant burden of the widespread seasonal infection on families and health care systems. Artisan Partners, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Shares of Merck & Co., Inc. (NYSE:MRK), a health care solutions company, were down 9%. Operating results have been solid, with Q4 earnings beating expectations, but investors were more focused on the continued weak demand in China for Gardasil, a vaccine for human papillomavirus (HPV), and the company's decision to pause vaccine shipments through at least mid-2025 to pare inventories. Though recent Gardasil setbacks have weighed on sentiment, the overarching issue for shareholders remains the success of Merck's late-stage pipeline to replace sales that will be lost when blockbuster oncology drug Keytruda (50% of Q4sales) comes off patent in 2028. As shares sell cheaply at just 10X earnings, Merck seems to be getting little credit from investors for the 60+ programs it has in clinical development, despite having several solid and large new product opportunities. Additionally, the company's strong balance sheet and robust free cash flow provide it multiple options for future partnerships and acquisitions, besides return of capital to shareholders via dividends and share repurchases.' While we acknowledge the potential of MRK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds' investor letters by entering your email address below. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
